Page last updated: 2024-08-24

gemcitabine and Leukoencephalopathy Syndrome, Posterior

gemcitabine has been researched along with Leukoencephalopathy Syndrome, Posterior in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Schaub, JR; Tang, SC1
Anton-Pascual, B; Calzas-Rodriguez, J; Guerra-Martinez, JA; Malon-Gimenez, D; Olmo-Sanchez, A; Sanchez-Cendra, C1
Bardutzky, J; Dechent, F; Dersch, R; Doostkam, S; Goller, K; Meckel, S; Stich, O; Weiller, C1
Cherniawsky, H; Ho, M; Merchant, N; Sawyer, M1
Bhatt, A; Farooq, MU; Kassab, M; Majid, A1
Fujiwara, H; Hagiuda, J; Hoshino, H; Kikuchi, E; Maeda, T; Matsumoto, K; Miyajima, A; Nakagawa, K; Oya, M; Yazawa, S1
Findlay, MP; Han, CH1
Chang, Y; Littman, SJ; Mbeo, G1
Belfiglio, M; Cioffi, P; Grappasonni, I; Laudadio, L; Nuzzo, A; Petrelli, F1
George, TJ; Rajasekhar, A1

Reviews

1 review(s) available for gemcitabine and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome.
    The American journal of the medical sciences, 2021, Volume: 361, Issue:6

    Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Middle Aged; Posterior Leukoencephalopathy Syndrome; Time Factors

2021

Other Studies

9 other study(ies) available for gemcitabine and Leukoencephalopathy Syndrome, Posterior

ArticleYear
[Posterior reversible encephalopathy syndrome associated to chemotherapy. Gemcitabine as the causative agent].
    Revista de neurologia, 2017, Jun-16, Volume: 64, Issue:12

    Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Posterior Leukoencephalopathy Syndrome

2017
Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.
    Journal of neurology, 2013, Volume: 260, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Immunologic Factors; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome

2013
A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.
    Medicine, 2017, Volume: 96, Issue:8

    Topics: Antineoplastic Agents; Brain; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Posterior Leukoencephalopathy Syndrome

2017
Chemotherapy-related posterior reversible leukoencephalopathy syndrome.
    Nature clinical practice. Neurology, 2009, Volume: 5, Issue:3

    Topics: Anticonvulsants; Antineoplastic Agents; Brain; Carboplatin; Deoxycytidine; Diagnosis, Differential; Electroencephalography; Female; Gemcitabine; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Small Cell Lung Carcinoma; Status Epilepticus; Tomography, X-Ray Computed

2009
Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
    International journal of clinical oncology, 2010, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Posterior Leukoencephalopathy Syndrome; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

2010
Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
    Internal medicine journal, 2010, Volume: 40, Issue:2

    Topics: Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Posterior Leukoencephalopathy Syndrome

2010
Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Journal of gastrointestinal cancer, 2012, Volume: 43, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Female; Gemcitabine; Humans; Hypertension; Magnetic Resonance Imaging; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Prognosis; Seizures

2012
Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:2

    Topics: Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Posterior Leukoencephalopathy Syndrome

2012
Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.
    The oncologist, 2007, Volume: 12, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Brain; Central Nervous System; Deoxycytidine; Female; Gemcitabine; Humans; Magnetic Resonance Imaging; Medical Oncology; Neoplasms; Posterior Leukoencephalopathy Syndrome; Risk Factors; Treatment Outcome

2007